![]() |
市场调查报告书
商品编码
1725110
2032 年静脉穿刺程序市场预测:按产品类型、静脉类型、技术、应用、最终用户和地区进行的全球分析Venipuncture Procedure Market Forecasts to 2032 - Global Analysis By Product Type (Needles, Syringes, Blood Collection Tubes, and Other Product Types), Vein Type, Technique, Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球静脉穿刺手术市场预计在 2025 年达到 14.2 亿美元,预计到 2032 年将达到 24.3 亿美元,预测期内的复合年增长率为 8.0%。
静脉穿刺是一种将针头插入静脉以抽血或註射药物或液体的医疗程序。它通常在手臂上进行,对于诊断测试、输血和静脉治疗至关重要。此过程需要技巧来尽量减少不适并减少併发症。它由经过培训的医疗保健专业人员(例如采血员、护士和医疗技术人员)在医院、诊所和实验室定期进行。
根据美国疾病管制与预防中心2021年发布的数据,每年约有80.5万人接受此检测。美国每年约有 805,000 人心臟病发作,20 岁以上的成年人中约有二十分之一患有冠状动脉疾病 (CAD)。
慢性病增多
糖尿病、癌症和心血管疾病等慢性疾病的盛行率不断上升,推动了静脉穿刺手术的需求。慢性疾病通常需要定期验血以进行诊断、治疗监测和管理,从而推动市场发展。医疗保健基础设施和诊断工具的进步极大地改善了静脉穿刺服务的可近性。政府促进早期诊断和预防性医疗保健的倡议进一步推动了这种日益增长的需求。此外,人口老化使得人们更容易患上慢性疾病,这也推动了静脉穿刺服务的需求。
缺乏训练有素的采血员
静脉穿刺手术市场因熟练采血师严重短缺而受到限制。经过适当培训的人员对于确保安全有效地采集血液以及最大限度地减少错误和患者不适的风险至关重要。许多地区缺乏适当的培训计划和资格,加剧了这个问题。此外,医疗保健行业的高员工离职率也导致经验丰富的专业人员短缺。这项挑战在卫生资源有限的农村和欠发达地区尤为明显。
门诊和居家医疗服务的成长
人们对门诊和家庭医疗保健服务的日益增长的偏好为静脉穿刺手术市场创造了巨大的机会。这些环境提供了便利性、节省了成本并提高了患者的舒适度,从而推动了它们的普及。就地检验和可携式诊断设备的扩展进一步推动了这一趋势。技术的进步使得在传统临床环境之外进行精确的静脉穿刺手术成为可能。此外,对个人化医疗保健解决方案的需求不断增长与这些服务的成长相吻合。
对非侵入性诊断的偏好日益增长
非侵入性诊断技术的日益普及对静脉穿刺手术市场构成了威胁。与抽血相比,唾液、尿液检查和呼吸检测等方法侵入性较小,对患者也较友善。这些技巧对于在静脉穿刺过程中感到焦虑或不适的患者特别有吸引力。此外,穿戴式健康监测设备的进步也减少了频繁抽血的需求。随着这些替代疗法变得更加容易取得和可靠,它们可能会取代传统的静脉穿刺。
COVID-19的影响
COVID-19 疫情对静脉穿刺手术市场产生了重大影响。最初,医疗系统的封锁和中断导致非紧急血液检测和诊断的减少。然而,这场大流行也凸显了及时诊断服务的重要性,这有助于最终的康復。疫情过后,人们对定期健康检查和诊断的认识提高预计将推动成长。这场大流行凸显了静脉穿刺在医疗保健中的重要作用,并强化了其长期重要性。
预计头部静脉段在预测期内将是最大的。
由于头静脉采血具有良好的可及性和易用性,预计在预测期内将占据最大的市场占有率。此静脉通常用于静脉穿刺手术,尤其是在门诊病人和急诊环境。其突出的位置有助于最大限度地减少併发症并提高患者的舒适度,因此越来越受到医疗保健专业人士的偏好。此外,对慢性病常规诊断和监测的需求不断增加,进一步推动了头静脉的利用。
预计在预测期内,医院部门的复合年增长率最高。
由于医院部门是静脉穿刺服务的主要提供者,预计在预测期内将出现最高的成长率。医院正在推动市场占有率,因为它们要处理大量需要采血的诊断和治疗程序。医院实验室先进技术与自动化的结合提高了静脉穿刺过程的准确性和效率。此外,医院处理复杂病例和紧急情况的能力使其成为市场中的主要企业。
在预测期内,亚太地区预计将占据最大的市场占有率,这得益于其快速扩张的医疗保健基础设施。该地区人口众多,慢性病盛行率不断上升,增加了静脉穿刺的需求。政府推动疾病早期发现和预防性医疗保健的倡议将进一步推动市场成长。此外,可支配收入的增加和医疗保健服务的改善也促进了诊断活动的增加。
预计北美地区在预测期内将呈现最高的复合年增长率。这是得益于先进的医疗保健系统和大量的诊断测试。该地区受益于大规模的医疗保健投资和对研发的高度重视。诊断技术和自动化方面的创新支持了静脉穿刺的高效进行。此外,人们对预防性医疗保健和定期检查的认识不断提高,也推动市场的发展。
According to Stratistics MRC, the Global Venipuncture Procedure Market is accounted for $1.42 billion in 2025 and is expected to reach $2.43 billion by 2032 growing at a CAGR of 8.0% during the forecast period. Venipuncture is a medical procedure that involves puncturing a vein with a needle to withdraw blood or administer medications and fluids. Commonly performed on the arm, it is essential for diagnostic testing, transfusions, and intravenous therapy. The procedure requires skill to ensure minimal discomfort and reduce complications. It is routinely conducted in hospitals, clinics, and laboratories by trained healthcare professionals such as phlebotomists, nurses, or medical technicians.
According to the Centers for Disease Control and Prevention data published in 2021. Every year, about 805,000 people in the U.S. suffered with heart attack and about 1 in 20 adults aged 20 and older have coronary artery disease (CAD).
Rising prevalence of chronic diseases
The increasing prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular conditions, is driving the demand for venipuncture procedures. Chronic diseases often require routine blood tests for diagnosis, treatment monitoring, and management, thus boosting the market. With advancements in healthcare infrastructure and diagnostic tools, access to venipuncture services has improved significantly. This growing demand is further supported by government initiatives promoting early diagnosis and preventive healthcare. Additionally, an aging population prone to chronic conditions adds to the necessity of venipuncture services.
Shortage of trained phlebotomists
The venipuncture procedure market is restrained by a notable shortage of skilled phlebotomists. Properly trained personnel are crucial to ensure safe and effective blood collection, minimizing the risk of errors and patient discomfort. The lack of adequate training programs and certifications in many regions exacerbates this issue. Moreover, high staff turnover in the healthcare sector contributes to the scarcity of experienced professionals. This challenge is particularly pronounced in rural and underdeveloped areas, where healthcare resources are limited.
Growth in outpatient and home care services
The increasing preference for outpatient care and home healthcare services presents a significant opportunity for the venipuncture procedure market. These settings offer convenience, reduced costs, and enhanced patient comfort, driving their adoption. The expansion of point-of-care testing and portable diagnostic devices further supports this trend. Advances in technology enable precise venipuncture procedures outside traditional clinical environments. Moreover, the rising demand for personalized healthcare solutions aligns with the growth of these services.
Rising preference for non-invasive diagnostic alternatives
The growing popularity of non-invasive diagnostic techniques poses a threat to the venipuncture procedure market. Methods such as saliva, urine, and breath tests offer a less invasive and more patient-friendly alternative to blood collection. These technologies are particularly appealing to patients who experience anxiety or discomfort during venipuncture. Additionally, advancements in wearable health monitoring devices are reducing the need for frequent blood draws. As these alternatives become more accessible and reliable, they may displace traditional venipuncture procedures.
Covid-19 Impact
The COVID-19 pandemic significantly impacted the venipuncture procedure market. During the initial phases, lockdowns and healthcare system disruptions led to a decline in non-urgent blood tests and diagnostics. However, the pandemic also highlighted the importance of timely diagnostic services, leading to an eventual recovery. Post-pandemic, heightened awareness about regular health check-ups and diagnostics is expected to drive growth. The pandemic underscored the critical role of venipuncture in healthcare, reinforcing its importance in the long term.
The cephalic vein segment is expected to be the largest during the forecast period
The cephalic vein segment is expected to account for the largest market share during the forecast period, due to its accessibility and ease of use for blood collection. This vein is commonly chosen for venipuncture procedures, especially in outpatient and emergency settings. Its prominent location minimizes complications and enhances patient comfort, increasing its preference among healthcare professionals. Additionally, the growing demand for routine diagnostics and chronic disease monitoring further drives the utilization of cephalic vein.
The hospitals segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the hospitals segment is predicted to witness the highest growth rate, due to their role as primary providers of venipuncture services. Hospitals handle a high volume of diagnostic and therapeutic procedures requiring blood collection, driving their market share. The integration of advanced technologies and automation in hospital labs enhances the accuracy and efficiency of venipuncture processes. Additionally, hospitals' ability to cater to complex cases and emergency situations positions them as key players in the market.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to its rapidly expanding healthcare infrastructure. The region's large population and increasing prevalence of chronic diseases drive the demand for venipuncture procedures. Government initiatives promoting early disease detection and preventive care further enhance market growth. Additionally, rising disposable incomes and improved access to healthcare services contribute to increased diagnostic activities.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to its advanced healthcare systems and high diagnostic test volumes. The region benefits from extensive healthcare investments and a strong focus on research and development. Innovations in diagnostic technologies and automation support the efficient conduct of venipuncture procedures. Moreover, increasing awareness about preventive healthcare and routine check-ups drives the market.
Key players in the market
Some of the key players profiled in the Venipuncture Procedure Market include Becton, Dickinson and Company (BD), Terumo Corporation, Quest Diagnostics, Greiner Bio-One International, Fresenius Kabi AG, AccuVein Inc., Smiths Medical, B. Braun Medical, Christie Medical Holdings, Inc., TransLite, LLC, Sharn Anesthesia, Laboratory Corporation of America Holdings (LabCorp), Eurofins Scientific, BioReference Health, LLC, and UNILABS.
In April 2025, BD announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) and the commercial launch of Phasix(TM) ST Umbilical Hernia Patch, the first and only fully absorbable hernia patch on the market designed specifically for umbilical hernias.
In March 2025, Terumo Vietnam Medical Equipment and Daiichi Sankyo Vietnam have signed a Memorandum of Understanding (MoU) to collaborate on advancing cardiovascular expertise in Vietnam. The initiative aims to support healthcare professionals in updating their knowledge and skills in interventional cardiology.